Parkinson's disease
Conditions
Interventions
During the study, two skin swabs will be collected from the middle of each participant’s back. The procedure will be performed using a cotton swab and is entirely painless. In addition, some medical i
Sponsors
Amsterdam UMC
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Parkinson's group:Age between 40-75 years;The diagnosis of Parkinson’s disease must be confirmed with certainty.Control group:Age between 40-75 years.
Exclusion criteria
Exclusion criteria: Parkinson’s Group:Inability to provide consent;Use of bodylotion on the mid-back within the 24 hours prior to the study.Control Group:Inability to provide consent;Use of bodylotion on the mid-back within the 24 hours prior to the study;Presence of acute or chronic neurological or psychiatric disorders;History of other diseases or treatments that could significantly affect the brain (e.g., brain irradiation).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint of the study is the sebum profile. The objective is to investigate whether there are differences in sebum profiles between patients with Parkinson’s disease (Parkinson’s group) and individuals without the disease (control group). | — |
Secondary
| Measure | Time frame |
|---|---|
| To validate sebum profiles. | — |
Countries
Netherlands
Contacts
Public ContactA.M. Rijs
Vrije Universiteit
Outcome results
None listed